Sequence information
Variant position: 607 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 854 The length of the canonical sequence.
Location on the sequence:
ALLEAKMHAISGNHFWTAKD
L TEEIRSLTSEREGLEGLLSK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ALLEAKMHAISGNHFWTAKDL TEEIRSLTSEREGLEGLLSK
Mouse ALLEAKMLALSGSCFSTAKEL TEEIWALSSEREGLEMFLGR
Rat ALLEAKMLALSGSCFSTAKEL AEEIWAVSSEREGLEMFLGR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 854
Disrupted in schizophrenia 1 protein
Region
293 – 696
Interaction with TRAF3IP1
Region
446 – 854
Necessary and sufficient for interaction with PCNT and localization at the centrosome
Region
598 – 854
Interaction with ATF4 and ATF5
Coiled coil
602 – 666
Alternative sequence
357 – 854
Missing. In isoform 10.
Alternative sequence
370 – 854
Missing. In isoform 4.
Alternative sequence
552 – 854
Missing. In isoform 11.
Alternative sequence
580 – 854
Missing. In isoform 6 and isoform 7.
Literature citations
Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder.
Hodgkinson C.A.; Goldman D.; Jaeger J.; Persaud S.; Kane J.M.; Lipsky R.H.; Malhotra A.K.;
Am. J. Hum. Genet. 75:862-872(2004)
Cited for: INVOLVEMENT IN SCZD9; VARIANTS VAL-5 AND PHE-607;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.